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Abstract
Neutrophil-mediated tissue injury is a shared pathogenesis of both chronic pulmonary diseases and
acute responses to pathogens, allergens, and airborne pollutants. Interventions to minimize toxic
effects of neutrophil-derived oxidants and proteases are usually limited to corticosteroids, which
can have adverse side effects. We used a rodent model of endotoxin-induced lung injury to test the
hypothesis that the dietary supplement γ-tocopherol (γT), a natural form of vitamin E with
antioxidant and novel anti-inflammatory properties, will protect from adverse nasal and
pulmonary inflammatory responses induced by endotoxin (lipopolysaccharide; LPS). Male Fisher
F344 rats were intranasally (i.n.) instilled with LPS for 2 consecutive days. Beginning 2 days
before i.n. LPS, the rats were gavaged daily with 30 mg/kg γT. Twenty-four hours after the last
i.n. LPS, bronchoalveolar lavage fluid (BALF) was collected, and pulmonary and nasal tissues
were analyzed for gene expression and morphometric analyses of neutrophils and intraepithelial
mucosubstances (IM). LPS caused increased BALF total cells (70% increase), neutrophils (300%),
protein (35%), PGE2 (500%), and secreted mucins (75%). Robust increases in neutrophils and IM
were detected in conducting airways. Pulmonary expression of MUC5AC, MIP-2, CINC-1, and
MCP-1 was elevated three- to eightfold by LPS. Treatment with γT inhibited LPS-induced
increases in BALF total cells, neutrophils, protein, PGE2, and secreted mucins, as well as IM and
tissue neutrophil influx. Furthermore γT induced the expression of the regulatory cytokines IL-10
and IFN-γ while decreasing MUC5AC, MIP-2, CINC-1, and MCP-1. These data demonstrate
novel therapeutic effects of the dietary vitamin E γT promoting anti-inflammatory pathways to
protect from neutrophil-mediated lung injury.
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Chronic neutrophilic lung diseases such chronic obstructive pulmonary disease (COPD) and
cystic fibrosis are the second leading contributor to disability-adjusted life years in North
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America [1]. Polymorphonuclear leukocytes (neutrophils; PMNs) are also the primary
airway granulocytes in severe asthma, as well as asthma diagnoses associated with the obese
and the elderly [2,3]. Furthermore, airway infiltration and activation of PMNs are critical
features in acute lung injury in response to inhalation exposure to airborne toxicants such as
ozone, particulate matter, and biogenic toxicants [4–6]. As such, interventions that control
the recruitment or activation of airway PMNs would have broad applications in the
mitigation of the morbidity associated with a number of acute and chronic airway diseases.
Recruitment of PMNs into lung airspaces occurs in response to a variety of airway stimuli
and involves the stepwise process of adhesion molecule expression on PMNs, epithelial
cells, and endothelial cells in both the pulmonary capillaries and the bronchial venules [7].
Reactive oxygen species (ROS) and elastase released from emigrated neutrophils are
primary factors in the pathogenesis of neutrophil-mediated airway injury and disease [8,9].
Interventions to protect from oxidant-induced tissue injury mediated by PMNs include,
among others, glucocorticosteroids [10]; inhibitors of NADPH oxidase, which is responsible
PMN oxidative burst [11]; and antioxidants that interact directly with and neutralize ROS.
Included in the last category are micronutrients with antioxidant properties such as α-
tocopherol (αT) and ascorbate (vitamin C), both of which have been used to reverse oxidant-
mediated pulmonary injury with varying degrees of success [12,13].
We have previously shown that γ-tocopherol (γT), the major form of vitamin E in U.S. diets,
can prevent eosinophilic inflammation and airway remodeling in experimental asthma [14]
and in ozone exacerbation of allergic rhinitis in laboratory rodents [15]. In subsequent
studies in vitro we found that γT inhibits IL-13-induced production of eotaxin from airway
epithelial cells [16], an effect that would target eosinophil recruitment and explain the
antiallergic effects we documented in rodent studies. Recently members of our group
described the γT-mediated interruption of neutrophil signal transduction pathways and γT-
caused decreased production of inflammatory leukotrienes [17]. This led us to hypothesize
that, like the inhibition of airway eosinophil recruitment, γT would block the recruitment
and activation of neutrophils into lung and thereby inhibit tissue injury associated with
neutrophil mediator production. In the current study we used a well-characterized rodent
model of endotoxin-induced airway injury that is dependent on neutrophils [18] to test the
effects of dietary supplementation with γT on the treatment-related changes in histological,
morphological, biochemical, and molecular endpoints. Herein we describe attenuation by γT
of endotoxin-induced inflammatory cell recruitment, cytokine gene expression, prostanoid
production, and overproduction of mucus in both nasal and pulmonary airways.
Materials and methods
Animals
Male F344/N rats, 9–10 weeks of age, were obtained from Harlan Sprague–Dawley
(Indianapolis, IN, USA) and randomly assigned to one of six experimental groups (n = 7/
group). Rats were used in accordance with guidelines set forth by the All-University
Committee on Animal Use and Care at Michigan State University. Animals were housed
two per cage in polycarbonate boxes on Aspen chip bedding, covered with filter lids, and
had free access to tap water and food (Tek Lad 22/5 Rodent Diet W 8649; Harlan).
Treatment protocols
Rats were instilled intranasally (i.n.) with 150-µl volumes of endotoxin (lipopolysaccharide
(LPS) from Pseudomonas aeruginosa; Sigma Chemical Co., St. Louis, MO, USA) in
pyrogen-free saline into each nasal passage (300 µl total volume), for total doses of 0, 5, or
20 µg (equivalent to 2500 and 10,000 endotoxin units (EU), respectively). For instillations,
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rats were lightly anesthetized with 4% isoflurane in oxygen. A second instillation was given
24 h later. Intranasal challenge procedures were conducted between 10:00 and 11:00 AM
each day.
Two days before i.n. LPS procedures, rats were begun on a daily supplementation regimen
of 30 mg/kg body wt of D-γ-tocopherol (highly purified R,R,R isomer, naturally occurring
96% pure; Yasoo Health, Johnson City, TN, USA) diluted in 0.5 ml tocopherol-stripped
corn oil (Dyets, Bethlehem, PA, USA). Stock dilutions were kept under nitrogen at 4 °C and
contained no other tocopherols, tocotrienols, or oxidation products. γT was administered by
oral gavage each day at 6:00 PM for 4 consecutive days, such that two administrations of γT
were given before the first i.n. LPS dose. Animals were euthanized and tissues were
collected 24 h after the last dose of i.n. LPS. The treatment and supplementation protocol is
depicted in Fig. 1A. Separate animals (n = 3/group) were used to determine circulating γT
levels 24 h after 2, 3, and 4 days of supplementation.
Necropsy and tissue preparation
Animals were anesthetized with sodium pentobarbital (50 mg/kg), a midline laparotomy was
performed, 4 ml of blood was drawn into a Vacutainer for separation of plasma, and the
animals were exsanguinated by cutting the abdominal aorta. Immediately after death, the
trachea was exposed and cannulated, and the heart and lung were excised en bloc. The
bronchus to the left lung was temporarily closed with a hemostatic clamp, and 5 ml of sterile
saline was instilled through the tracheal cannula and withdrawn to recover bronchoalveolar
lavage fluid (BALF) from the right lung lobes. A second saline lavage was performed and
combined with the first.
After lavage, the right lung lobes were ligated and removed. The right cranial lobe was also
excised and placed in RNAlater (Qiagen, Valencia, CA, USA) and held at 4 °C until further
processing for RNA isolation. The clamp was removed from the left bronchus, and the left
lobe was inflated under constant pressure (30 cm H2O) with neutral-buffered formalin for 2
h while immersed in a large volume of fixative. Heads were removed and placed in fixative.
Twenty-four hours later, two sections were excised from the left lung lobe, at the levels of
the 5th and 11th airway generation, to sample proximal and distal airways, respectively [26].
Heads were decalcified in 13% formic acid for 5 days. Nasal sections were taken from the
anterior nasal cavity by making a perpendicular cut to the hard palate at the level
immediately posterior to the upper incisors. Tissue blocks were then embedded in paraffin,
and 5- to 6-µm-thick sections were cut from the anterior surfaces. Lung sections were
stained with hematoxylin and eosin for routine histology and with Alcian blue (pH 2.5)/
periodic acid–Schiff (AB/PAS) to detect intraepithelial mucosubstances (IM). PMNs within
the lung and nasal sections were immunohistochemically identified by using a rabbit-derived
antibody to rat PMNs (gift from Robert A. Roth, Michigan State University). Briefly,
formalin-fixed tissue sections were digested for 10 min in a pepsin:HCl solution before
incubation overnight with rat PMN antiserum. These immunohistochemical sections were
then incubated with rabbit IgG conjugated to alkaline phosphatase, which reacted with a
substrate (Vector Red Substrate Kit; Vector Laboratories, Burlingame, CA, USA) to form a
red stain as imaged under a light microscope. The samples were counterstained with
hematoxylin. Positively stained PMNs were identified not only by the red color but by other
distinct morphological features, including cell size and a multilobular nucleus. Site-specific
morphometry of IM and PMNs was conducted in the respiratory epithelium and submucosa,
respectively, of the proximal and distal axial pulmonary axial airways and of the proximal
nasal septum.
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Concentrations of plasma γT were determined as described previously [14]. Briefly, plasma
was extracted and eluted by HPLC approaches and concentrations of tocopherols were
determined via electrochemical detection by comparison to external standards.
Bronchoalveolar lavage
Total leukocytes in BALF were enumerated with a hemocytometer, and fractions of
eosinophils, PMNs, macrophages, and lymphocytes were determined in a cytospin sample
stained with Diff-Quik (Dade Behring, Newark, DE, USA). Total protein was determined by
the bicinchoninic acid method (BCA Kit 23225; Thermo Fisher, Rockford, IL, USA).
Secretion of mucosubstances into airways was estimated by an ELISA for mucin
glycoprotein 5AC using a mouse monoclonal antibody to the human MUC5AC protein
(Mucin 5AC Ab-1; Neomarkers, Fremont, CA, USA) that has reactivity to the rat rMuc5AC
core protein. Bound primary antibody was detected with a biotinylated rabbit anti-mouse
secondary antibody and quantitated using horseradish peroxidase-conjugated avidin/biotin
complex (ABC Reagent; Vector Laboratories) and a fluorescent substrate (QuantaBlue;
Pierce Chemical, Rockford, IL, USA). Prostaglandin E2 (PGE2) was determined by
commercial EIA using a Prostaglandin E Metabolite Kit (Cayman Chemical, Ann Arbor,
MI, USA).
Morphometry of stored intraepithelial mucosubstances
To estimate the amount of the intraepithelial mucosubstances in lining maxilloturbinates and
the respiratory epithelium lining the axial pulmonary airways, the volume density of AB/
PAS-stained mucosubstances was quantified using computerized image analysis and
standard morphometric techniques. Briefly, the area of AB/PAS-stained mucosubstance was
estimated by setting colorized thresholds to highlight only IM, and these areas were then
automatically calculated using the public domain NIH Image program (written by Wayne
Rasband, U.S. National Institutes of Health, and available at http//rsb.info.nih.gov/nih-
image/). The length of the basal lamina underlying the surface epithelium was calculated
from the contour length of the digitized image of the basal lamina. The volume of stored
mucosubstances per unit of surface area of epithelial basal lamina was estimated using the
method described in detail by Harkema and Hotchkiss [19] and was expressed as nanoliters
of intraepithelial mucosubstances per square millimeter of basal lamina (i.e., volume
density).
Morphometry of submucosal PMNs
The numeric density of PMNs in the mucosa underlying the respiratory epithelium of
conducting pulmonary airways was determined by counting PMN-positive stained cells with
distinct neutrophil morphology. The length of the basal lamina was calculated from its
contour length in a digitized image as described above, and the data were expressed as the
number of PMNs divided by the length of the underlying basal lamina.
Mucin gene expression
Total RNA was extracted using the RNeasy Mini Kit according to the manufacturer’s
instructions (Qiagen). The evaluation of relative mRNA expression levels of the
chemoattractant cytokines MIP-2, CINC-1, and MCP-1 and of the mucin glycoprotein 5AC
was performed by two-step RT-PCR using manufacturer protocols (Applied Biosystems,
Foster City, CA, USA). Briefly, reverse transcription was performed using High Capacity
cDNA Archive Kit reagents. Quantitative mRNA expression analysis was performed using
an ABI PRISM 7900 HT sequence detection system at Michigan State University’s
Research Technology Support Facility using TaqMan Gene Expression Assay reagents
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(Applied Biosystems). Relative gene expression was normalized to 18S. Data were
expressed as fold increase in RNA expression compared to control animals, which were set
at a value of 1.
Statistical analysis
Data are expressed as the mean ± SE. Grubb’s outlier test was used to determine statistical
outliers. Data were analyzed using a completely randomized analysis of variance (SigmaStat
version 12; Jandel Scientific). Multiple comparisons were made by Student–Newman–Keuls
post hoc test. Criterion for significance was set at p ≤ 0.05.
Results
Circulating γT
Daily oral gavage with 30 mg/kg γT led to a four- to fivefold increase in plasma vitamin E
to approximately 1.5 µM within 2 days (Fig. 1B). Repeated supplementation did not induce
further increase in plasma γT.
Bronchoalveolar lavage fluid
Instillation with 5 or 20 µg LPS induced robust airway inflammation as indicated by
increases in BALF PMNs (Table 1). Increased BALF macrophages were elicited by 20, but
not 5 µg LPS. Supplementation with γT attenuated LPS-induced inflammation to control
levels for both PMNs and macrophages.
Total protein (Fig. 2A) and mucin glycoprotein 5AC (Fig. 2B; an estimate of mucus
secretion) were significantly increased in BALF after instillation with either 5 or 20 µg LPS.
Endotoxin-induced increases in total protein were completely blocked by γT
supplementation. Increases in mucus secretion were not significant in γT-supplemented rats
given 5 µg LPS and were significantly inhibited in rats given 20 µg LPS. Instillation with 5
or 20 µg LPS induced accumulation of both GRO-KC and PGE2 in BALF, which was
completely inhibited in rats given γT (Fig. 2C).
Pulmonary mucous cell metaplasia
Instillation with 20, but not 5 µg LPS induced mucous cell metaplasia in proximal and distal
axial airways as indicated by increased IM in proximal (230% increase) and distal (900%)
conducting airways in rats (Fig. 3). Increases in IM after instillation with 5 µg LPS were not
significant. Supplementation with γT reduced LPS-induced IM responses to control levels.
Histochemical detection of IM was sparse in conducting airways of control rats given saline
and corn oil, but robust increases in IM were induced after treatment with LPS (Fig. 3C).
Supplementation with γT in LPS-treated rats resulted in minimal IM accumulation.
Pulmonary neutrophils
Instillation with LPS induced significant infiltration of PMNs into the submucosa of
proximal (400% increase) and distal (600%) axial airways (Fig. 4A and B, respectively).
Responses were equivalent in rats given either 5 or 20 µg LPS. PMN infiltration induced by
both doses of LPS was reduced to control levels in rats supplemented with γT.
Immunohistological detection of PMNs was minimal in conducting airways of control rats,
but a marked infiltration occurred in the parenchyma and submucosa of conducting airways
after treatment with LPS (Fig. 4C). LPS-induced recruitment of pulmonary PMNs was
attenuated in rats supplemented with γT.
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Expression of the genes for the chemotactic and inflammatory proteins MIP-2, CINC-1, and
MCP-1 was significantly elevated (two- to threefold) only after instillation with 20 µg LPS
(Fig. 5). Elevations in the mucin gene MUC5AC expression were evident in rats given 5 or
20 µg LPS. Supplementation with γT blocked all LPS-induced increases in pulmonary gene
expression. Pulmonary expression of IFN-γ and IL-10 was significantly increased only in
rats given endotoxin and supplemented with γT.
Nasal inflammatory and mucous cell responses
Both 5 and 20 µg LPS caused increased IM (38% increase) and accumulation of submucosal
PMNs (400%) in the nasal septum that were attenuated by γT supplementation (Fig. 6A and
B, respectively). Mucous goblet cells in the respiratory epithelium lining the midseptum
appeared enlarged and more numerous in rats instilled with LPS (Fig. 6C). Few PMNs were
detected in the submucosa underlying the epithelium in midseptum in control rats, but LPS
instillation caused a marked infiltration of PMNs in the subepithelial compartment (Fig.
6D). Supplementation with γT prevented both the mucous cell metaplasia and the
neutrophilic inflammation induced by LPS.
Discussion
Inhalation or airway instillation of endotoxin in laboratory rodents is well known to elicit
acute inflammatory responses that include neutrophil emigration and mucous cell metaplasia
[19–21]. In this study we demonstrate that dietary supplementation of rats with γT attenuates
endotoxin-induced airway cytokine production, inflammatory cell infiltration, and mucous
overproduction and hypersecretion. These findings are notable for the comprehensive
ameliorative effects in both nasal and pulmonary airways by γT against a potent airway
inflammagen after a relatively brief, 3-day pretreatment. Our results suggest that γT might
be an effective adjunct or alternative medicine to inhibit adverse airway responses during
exacerbation of bronchitis or chronic obstructive pulmonary diseases as well as nonallergic
rhinitis, which are characterized by neutrophilic inflammation and hypersecretion.
We have previously described how γT supplementation can attenuate allergic airway
inflammation during experimental asthma and rhinitis [14]. In that study, allergen-induced
eosinophil influx, mucus production, and TH2 cytokine expression were inhibited by γT
pretreatment. Specifically, nasal expression of interleukin-4, -5, and -13 was blocked, while
at the same time pulmonary expression of IFN-γ was increased in allergic rats. Those results
suggested to us that γT may activate TH1 pathways that might counter the allergen-induced
induction of TH2 mediators. However, our present results with a nonallergenic stimulus
such as endotoxin demonstrate a broader inflammation-modulating profile for γT.
Interestingly in this study we again detected a γT-associated increase in IFN-γ expression in
lungs with the highest dose of endotoxin (i.e., the most inflamed group), in addition to
expression of IL-10, which has an anti-inflammatory role in endotoxin-induced lung injury
[22]. These increases in regulatory cytokines were paralleled by decreases in LPS-induced
signals for PMN chemoattraction (MIP-2, GRO-KC) and mucus production (MUC5AC).
Taken together with our previous results, γT seems to have comparable therapeutic effects
against both acquired (TH2) and innate (TH1) immune stimuli in part by promoting the
production of regulatory cytokines such as IFN-γ and IL-10.
This demonstration of the general anti-inflammatory properties of γT in both endotoxin- and
allergen-induced airway injury models suggests that γT may act at a common upstream
pathway or pathways, similar to corticosteroids or nonsteroidal anti-inflammatory drugs.
Members of our group have previously described the high-affinity inhibitory capacity of a
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γT metabolite for cyclooxygenase [23], which effectively outcompetes arachidonic acid for
binding to the enzyme and blocking prostanoid synthesis. Here we demonstrate the
prevention of endotoxin-induced accumulation of PGE2 in BALF from rats pretreated with
γT. We have previously reported similar effects of γT to reduce PGE2 in allergic rat lungs,
where γT pretreatment also depressed production in airways of the cysteinyl leukotrienes
LTC4 and LTB4 [14]. However, we did not assess the role of leukotrienes or other
prostanoids in the current study.
Protection from endotoxin-induced inflammation by γT may be mediated by the inhibition
of atypical protein kinase C (aPKC), an enzyme critical to NF-κB activation by LPS in
macrophages [24]. Unlike classic PKC isoforms, aPKC’s such as PKCζ are insensitive to
regulation by calcium or diacyl glycerol and rather are modulated by intracellular adaptor
and regulator proteins. Our group recently used another γT isoform, γ-tocotrienol, to inhibit
PKCζ in human airway epithelial cells by the induction of prostate-apoptosis-response 4, an
endogenous negative regulator of aPKC [16]. Functional PKCζ is required for LPS-induced
expression of adhesion molecules and PMN chemoattractants in airway epithelium in vitro
[25] and the recruitment of PMN to the lungs in response to airway endotoxin in laboratory
rodents [26]. Furthermore its activation regulates appropriate adhesion molecule expression
on both endothelial cell and PMNs [27,28]. Thus, PKCζ is necessary in multiple cell types
involved in chemoattractant production and the subsequent transmigration of airway PMNs
in response to endotoxin, providing γT isoforms with several cellular targets for inhibition in
our model.
We have previously demonstrated that endotoxin-induced mucous cell metaplasia in rats is
dependent, in part, on airway emigration of PMNs [29]. Neutrophil-derived elastase,
reactive oxygen species, and matrix metalloproteinases have been implicated in mucin-gene
expression in airway cells [30,31]. In the present study low-dose endotoxin (5 µg) induced
airway and tissue PMN infiltration as well as expression of MUC5AC, but histological
detection of mucous cell metaplasia was evident only with 20 µg endotoxin. The difference
in gene expression and accumulation of intraepithelial mucous may be due to hypersecretion
of mucous, which may have surpassed mucin production at the lower endotoxin dose. It
should be noted that endotoxin can induce MUC5AC production in cultured airway
epithelium in the absence of PMNs, in part by PKCζ-mediated pathways that involve PGE2,
EGFR, and MMP-9 [32,33]. As such the inhibition by γT of airway remodeling to a
hypersecretory epithelium may be due to its effects on both neutrophil-dependent and
neutrophil-independent pathways.
Our results showing the switch from inflammatory cytokine and chemokine production to
anti-inflammatory mediators (IL-10, IFN-γ) extend our recent observations in an early phase
clinical study in which a γT-enriched vitamin E supplement diminished sputum neutrophil
numbers after inhaled endotoxin of similar potency (20,000 EU) in rats [34]. Interestingly,
although supplementation strategies differed between our animal and human studies with
regard to frequency and dosage, each regimen boosted circulating γT by similar 4- to 5-fold
increases. This is notable because the baseline and boosted circulating levels of γT were
approximately 10-fold greater in humans compared to rats in our respective studies. Despite
these differences, each intervention was efficacious against airway endotoxin responses. In a
separate animal study that assessed γT pharmacokinetics in rats (33 mg/kg/day), we
demonstrated 4-fold increases in γT content in both blood and pulmonary compartments,
with no significant effect on circulating αT [14]. Similar evaluations were not conducted in
the clinical study, but instead metabolism of γT was evaluated in serum as the appearance of
3-carboxychromanol (γ-CEHC), the terminal oxidation metabolite of γT [35]. Long-chain β-
oxidation metabolites of γT, including 9- and 13-carboxychromanols, inhibit COX-2 [23].
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Further studies are needed to describe the appearance of bioactive metabolites in both the
circulation and the pulmonary tissues of γT-supplemented rats.
Frequent systemic administration of γT has been reported to enhance eosinophilic
inflammation in mice sensitized and challenged to ovalbumin [36]. These studies, however,
used higher doses (100 mg/kg/day, for 9 days) than the current study (30 mg/kg/day, for 4
days) that resulted in up to sixfold higher concentrations of circulating γT than our dosing
regimen. Furthermore we provided γT by oral delivery rather than the subcutaneous route in
mice, which would bypass liver metabolism. This is an important distinction considering
that the anti-inflammatory metabolites of γT are known to be more potent than its precursor
in inhibiting COX-2- and 5-LOX-mediated eicosanoids [17,23]. Thus, the pharmacokinetics
and metabolism of γT may be critical for determining a therapeutic index that modulates
airway inflammation in response to different stimuli.
Our analyses focused solely on the inflammatory responses in the pulmonary compartment,
so effects of γT supplementation on circulating neutrophil numbers or cytokine production
are unknown. A second limitation of this study is the absence of analyses for bioactive γT
metabolites (e.g., CEHC), which we believe are the primary mediators that modulate
inflammatory responses. Also, our assessment of arachidonic acid (AA)-derived products
was limited to PGE2, rather than evaluation of other specific products of COX-2 and 5-LOX
as we have previously shown. Future studies to assess metabolism of both γT and AA will
yield important insights into the mechanism by which γT protects from airway
inflammation. Last, intervention with γT after LPS treatment would lend insight into the
therapeutic efficacy of targeting preexisting neutrophilia that occurs with COPD and other
chronic airway diseases.
In conclusion, dietary supplementation with γT had comprehensive anti-inflammatory
effects in an airway injury model of endotoxin-induced neutrophil inflammation and airway
remodeling. We have previously described similar ameliorative effects of γT in
experimental asthma, suggesting that common or proximal pathways of inflammatory
cascades are targeted by γT or its metabolites. In this regard inhibition of COX2 and PKCζ,
and production of regulatory cytokines such as IFN-γ and IL-10, may underlie the broad
anti-inflammatory effects associated with a relatively brief supplementation with γT.
Importantly, these results in animals provide a mechanistic foundation for our recent
observations in an early phase clinical study showing efficacy of γT to inhibit airway PMNs
induced by inhaled endotoxin. Taken together, γT might be an effective adjunct therapy for
adverse airway conditions characterized by neutrophilic inflammation and airway
remodeling, including bronchitis or chronic obstructive pulmonary diseases.
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Experimental protocol. (A) Rats were given 0 or 30 mg/kg γT in corn oil by oral gavage for
4 consecutive days and on the 3rd and 4th days were instilled with endotoxin (LPS; 0 or 20
µg) by intranasal instillation (i.n.), and tissues were collected as described under Materials
and methods on day 5. (B) Plasma concentration of γ-tocopherol was determined 24 h after
2, 3, and 4 days of supplementation in rats not given LPS. *p < 0.05, significantly different
from respective group given corn oil.
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Bronchoalveolar lavage proteins. Concentrations in BAL fluid of (A) total protein, (B)
mucin glycoprotein 5AC, (C) chemoattractant cytokine GRO-KC, and (D) prostaglandin E2
were determined as described under Materials and methods. a, significantly different from
respective group given 0 µg endotoxin; b, significantly different from respective group given
corn oil; c, significantly different from respective group given 5 µg endotoxin; p < 0.05.
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Mucous cell metaplasia. Intraepithelial mucosubstances in (A) proximal and (B) distal
conducting airways were quantified in lung sections by morphometric approaches as
described under Materials and methods. a, significantly different from respective group
given 0 µg endotoxin; b, significantly different from respective group given corn oil; c,
significantly different from respective group given 5 µg endotoxin; p < 0.05. (C)
Mucosubstances were histochemically detected in AB/PAS-stained tissues as blue positive
intracellular staining (arrows) of airway epithelium. ca, conducting airway; e, airway
epithelium; ap, alveolar parenchyma. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article).
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Pulmonary neutrophils. Neutrophils surrounding (A) proximal and (B) distal conducting
airways were enumerated in sections of lung tissues by morphometric approaches as
described under Materials and methods. a, significantly different from respective group
given 0 µg endotoxin; b, significantly different from respective group given corn oil; p <
0.05. (C) Neutrophils were identified by their staining positive (red cells) for anti-rat
neutrophil antibody in immunohistochemically processed tissues. ca, conducting airway; ap,
alveolar parenchyma.
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Pulmonary cytokines. Expression in lung tissues of (A) MIP-2, (B) CINC-1, (C) MCP-1, (D)
MUC5AC, (E) IFN-γ, and (F) IL-10 was determined by RT-PCR as described under
Materials and methods. a, significantly different from respective group given 0 µg
endotoxin; b, significantly different from respective group given corn oil; p < 0.05.
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Nasal responses. Mucous cell metaplasia was determined morphometrically as increases in
(A) intraepithelial mucosubstances in (C) the respiratory epithelium lining the nasal septum
stained with AB/PAS, which appear as intracellular blue-stained material (arrows). (B)
Submucosal neutrophils were enumerated by morphometric approaches in nasal septum in
immunohistochemically treated tissue to detect (D) cells staining positive (arrows, red cells)
for anti-rat neutrophil antibody, as described under Materials and methods. a, significantly
different from respective group given 0 µg endotoxin; b, significantly different from
respective group given corn oil; p < 0.05. na, nasal airway; e, epithelium, sm, submucosa.
(For interpretation of the references to color in this figure legend, the reader is referred to the
web version of this article).
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Table 1











Saline/corn oil 8.5 ± 0.3 0.9 ± 1.3 7.4 ± 0.3 0.1 ± 0.03
Saline/γ-tocopherol 8.3 ± 0.7 1.5 ± 0.7 6.5 ± 1.0 0.2 ± 0.1
5 µg LPS/corn oil 13.7 ± 2.0* 6.1 ± 1.7* 7.1 ± 0.7 0.8 ± 0.1
5 µg LPS/γ-tocopherol 12.1 ± 1.2* 2.9 ± 1.1** 8.3 ± 0.8 0.7 ± 0.2
20 µg LPS/corn oil 20.6 ± 2.5*,*** 9.4 ± 3.0*,*** 10.3 ± 1.5*,*** 0.9 ± 0.3
20 µg LPS/γ-tocopherol 11.4 ± 1.4** 2.0 ± 0.9** 8.9 ± 1.1 1.0 ± 0.4
Data are expressed as group mean ± SEM.
*
p < 0.05, significantly different from respective group given 0 µg endotoxin.
**
p < 0.05, significantly different from respective group given corn oil.
***
p < 0.05, significantly different from respective group given 5 µg endotoxin.
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